Profil
Edward J.
Rayner formerly worked at Syntara Ltd., as Non-Executive Director from 2018 to 2020, Arix Bioscience Plc, as Investment Director, Depixus SAS, as Director, AMP Capital Investors Ltd., as Senior Portfolio Manager & Analyst from 2011 to 2015, and AllianceBernstein Australia Ltd., as Head of Equities from 2010 to 2012.
Mr. Rayner received his graduate degree from the University of Oxford.
Anciens postes connus de Ed Rayner
| Sociétés | Poste | Fin |
|---|---|---|
| SYNTARA LIMITED | Directeur/Membre du Conseil | 14/08/2020 |
AMP Capital Investors Ltd.
 AMP Capital Investors Ltd. Investment ManagersFinance AMP Capital Investors Ltd. (AMPCI) is the wholly-owned investment management subsidiary of AMP Capital Holdings Ltd., ultimately held by financial group AMP Ltd. (ASX: AMP) in Australia. Founded in 1849 as the non-profit Australian Mutual Provident Society, the group is an Australian superannuation provider and asset manager. The firm is headquartered in Sydney with additional offices in New Zealand, Dubai, China, Hong Kong, India, Ireland, Japan, Luxembourg, UK and the US. They were one of the first to invest in infrastructure when they participated in the financing of the Sydney Harbour Tunnel in 1988. AMPCI is a socially responsible investor which manages a range of unlisted and listed infrastructure investments in Asia, Europe, North America, Australia and New Zealand as well as life insurance, institutional and mutual funds for the AMP group. | Analyst-Equity | 01/01/2015 |
AllianceBernstein Australia Ltd.
 AllianceBernstein Australia Ltd. Investment ManagersFinance AllianceBernstein (Australia) Ltd. (ABAL) is the Australian subsidiary of AllianceBernstein Holdings (Cayman) Ltd., ultimately owned by AXA Equitable Holdings, Inc. (NYSE: EQH) in the US. The firm is headquartered in Sydney with additional office in Melbourne. They provide diversified investment management services worldwide to institutional, high-net worth individuals and retail investors. | Head-Equity Investments | 01/04/2012 |
Depixus SAS
 Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation. | Directeur/Membre du Conseil | - |
| ARIX BIOSCIENCE PLC | Directeur en chef des Investissements | - |
Formation de Ed Rayner
| University of Oxford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARIX BIOSCIENCE PLC | Finance |
| SYNTARA LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
AllianceBernstein Australia Ltd.
AllianceBernstein Australia Ltd. Investment ManagersFinance AllianceBernstein (Australia) Ltd. (ABAL) is the Australian subsidiary of AllianceBernstein Holdings (Cayman) Ltd., ultimately owned by AXA Equitable Holdings, Inc. (NYSE: EQH) in the US. The firm is headquartered in Sydney with additional office in Melbourne. They provide diversified investment management services worldwide to institutional, high-net worth individuals and retail investors. | Finance |
AMP Capital Investors Ltd.
AMP Capital Investors Ltd. Investment ManagersFinance AMP Capital Investors Ltd. (AMPCI) is the wholly-owned investment management subsidiary of AMP Capital Holdings Ltd., ultimately held by financial group AMP Ltd. (ASX: AMP) in Australia. Founded in 1849 as the non-profit Australian Mutual Provident Society, the group is an Australian superannuation provider and asset manager. The firm is headquartered in Sydney with additional offices in New Zealand, Dubai, China, Hong Kong, India, Ireland, Japan, Luxembourg, UK and the US. They were one of the first to invest in infrastructure when they participated in the financing of the Sydney Harbour Tunnel in 1988. AMPCI is a socially responsible investor which manages a range of unlisted and listed infrastructure investments in Asia, Europe, North America, Australia and New Zealand as well as life insurance, institutional and mutual funds for the AMP group. | Finance |
Depixus SAS
Depixus SAS Miscellaneous Commercial ServicesCommercial Services Depixus SAS is a life science technology company based in Paris, France. Depixus is pioneering ground-breaking magna™ technology based on magnetic force spectroscopy, revealing dramatic new insights into complex biomolecular interactions at the single molecule level. The French company was founded by Gordon Hamilton and has been the CEO since incorporation. | Commercial Services |
